Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer
Closed
Phase 2
This trial is looking at a drug called GDC-0068 alongside abiraterone for prostate cancer that has stopped responding to hormone therapy.
The trial is for men with prostate cancer that has got worse despite having docetaxel chemotherapy.
Recruitment start: 17 October 2013
Recruitment end: 13 October 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Johann De Bono
Experimental Cancer Medicine Centre (ECMC)
Genentech Ltd
NIHR Clinical Research Network: Cancer
Last reviewed: 06 Nov 2014
CRUK internal database number: 9719